Lau johnson hamatake robert (43 risultati)

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condizione: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.

Condizione: New. pp. 376 1st Edition.

Condizione: New. pp. 376.

Condizione: New. pp. 376.

Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condizione: Very Good. First ed. in pristine condition; pages immaculate and unmarked; bindings tight; glossy pictorial boards show minimal shelf wear despite absence of d.j.s; b & w ill. Vol. I, "Detection, Genotypes and Characterization"has 349 p and Vol. II, "Immunology, Model Systems and Clinical Studies" has 572 p. Inserts comprise a letter to former owner, a physician, asking him to review the volumes forr the Clinical Chemistry journal, and forms for assignment of copyright for the reviews.…

Condizione: New. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 572 pages, biography. BIC Classification: MJCJ. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 30. Weight in Grams: 790. . 2010. 1st ed. Softcover of orig. ed. 2004. Paperback. . . . . …

Condizione: New. In English.

Condizione: New. In English.

Taschenbuch. Condizione: Neu. Hepatitis B and D Protocols | Volume 2: Immunology, Model Systems, and Clinical Studies | Robert K. Hamatake (u. a.) | Taschenbuch | Methods in Molecular Medicine | xxiii | Englisch | 2010 | Humana | EAN 9781617373633 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.…

Condizione: New. pp. 598.

Paperback. Condizione: Brand New. reprint edition. 572 pages. 9.00x6.00x1.25 inches. In Stock.

Condizione: New. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 572 pages, biography. BIC Classification: MJCJ. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 30. Weight in Grams: 790. . 2010. 1st ed. Softcover of orig. ed. 2004. Paperback. . . . . Books ship from the US and Ireland. …

Condizione: New. In English.

Condizione: New. This title discusses the significant worldwide health burden of hepatitis B virus (HBV) and hepatitis delta virus (HDV). It reviews research techniques used in the study of HBV and HDV and provides detailed descriptions of techniques that can be easily reproduced. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 376 pages, 109 black & white illustrations, 1 colour illustrations, biography. BIC Classification: MJJ. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 229 x 152 x 25. Weight in Grams: 725. . 2004. Hardback. . . . . …

Condizione: New. This work discusses the significant worldwide health burden of hepatitis B virus (HBV) and hepatitis delta virus (HDV) in two volumes; reviews research techniques used in the study of HBV and HDV; and provides detailed descriptions of techniques that can be easily reproduced. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 572 pages, biography. BIC Classification: MMFM. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 32. Weight in Grams: 1162. . 2004. Hardback. . . . . …

Condizione: New. pp. 600 1st Edition.

Hardcover. Condizione: New Books. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.…

Hardcover. Condizione: Brand New. 1st edition. 600 pages. 9.25x6.25x0.75 inches. In Stock.

Hardcover. Condizione: Brand New. 1st edition. 600 pages. 9.00x6.00x1.25 inches. In Stock.

Condizione: New. This title discusses the significant worldwide health burden of hepatitis B virus (HBV) and hepatitis delta virus (HDV). It reviews research techniques used in the study of HBV and HDV and provides detailed descriptions of techniques that can be easily reproduced. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 376 pages, 109 black & white illustrations, 1 colour illustrations, biography. BIC Classification: MJJ. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 229 x 152 x 25. Weight in Grams: 725. . 2004. Hardback. . . . . Books ship from the US and Ireland. …

Condizione: New. This work discusses the significant worldwide health burden of hepatitis B virus (HBV) and hepatitis delta virus (HDV) in two volumes; reviews research techniques used in the study of HBV and HDV; and provides detailed descriptions of techniques that can be easily reproduced. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 572 pages, biography. BIC Classification: MMFM. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 32. Weight in Grams: 1162. . 2004. Hardback. . . . . Books ship from the US and Ireland. …

Hardcover. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condizione: new. Questo è un articolo print on demand.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically infected with HBV presents an enormous public health challenge. For example, the major etiology of hepatocellular carcinoma (HCC) is chronic infection with HBV. Although fifth in cancer incidence, worldwide, HCC/liver cancer is the third leading cause of cancer death. The high mortality as- ciated with HCC arises because the disease is often detected late and is unresponsive to treatment. The number of deaths caused by PHCC is expected to rise over the next 20 years. Those chronically infected with HBV have a life risk of death to HCC of between 10 and 25%. Even the limited efficacy of drugs for the treatment of chronic HBV helps underscore the point that this disease is responsive to therapy. Drugs that target the polymerase (e. g. , hepsera and lamivudine) and interferon alpha represent two distinct strategies and show that both conventional antiviral and immunothe- peutic approaches can be used in management. However, the current inventory of therapeutics is inadequate. Interferon alpha is of limited value, only parenterally ava- able, and fraught with adverse reactions. 596 pp. Englisch. …

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically infected with HBV presents an enormous public health challenge. For example, the major etiology of hepatocellular carcinoma (HCC) is chronic infection with HBV. Although fifth in cancer incidence, worldwide, HCC/liver cancer is the third leading cause of cancer death. The high mortality as- ciated with HCC arises because the disease is often detected late and is unresponsive to treatment. The number of deaths caused by PHCC is expected to rise over the next 20 years. Those chronically infected with HBV have a life risk of death to HCC of between 10 and 25%. Even the limited efficacy of drugs for the treatment of chronic HBV helps underscore the point that this disease is responsive to therapy. Drugs that target the polymerase (e. g. , hepsera and lamivudine) and interferon alpha represent two distinct strategies and show that both conventional antiviral and immunothe- peutic approaches can be used in management. However, the current inventory of therapeutics is inadequate. Interferon alpha is of limited value, only parenterally ava- able, and fraught with adverse reactions.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 596 pp. Englisch.…